vs
Pulmatrix, Inc.（PULM）与REZOLVE AI PLC（RZLV）财务数据对比。点击上方公司名可切换其他公司
Pulmatrix, Inc.的季度营收约是REZOLVE AI PLC的1.3倍（$1.6M vs $1.2M），Pulmatrix, Inc.净利率更高（-374.4% vs -1078.8%，领先704.4%）
Pulmatrix Inc.是一家临床阶段生物制药企业，专注于研发针对慢性阻塞性肺病、囊性纤维化、特发性肺纤维化等严重呼吸系统疾病的创新吸入式疗法，依托专有干粉制剂技术提升吸入药物的疗效与安全性，推进多条候选药物管线研发。
REZOLVE AI PLC是总部位于英国的科技企业，开发人工智能驱动的移动互动与即时交易平台，支持用户直接从音频、视频、印刷内容中完成购买，服务欧洲、北美及部分亚太市场的零售、消费品与媒体客户。
PULM vs RZLV — 直观对比
营收规模更大
PULM
是对方的1.3倍
$1.2M
净利率更高
PULM
高出704.4%
-1078.8%
损益表 — Q2 FY2024 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $1.2M |
| 净利润 | $-5.8M | $-13.0M |
| 毛利率 | — | — |
| 营业利润率 | -380.2% | -808.4% |
| 净利率 | -374.4% | -1078.8% |
| 营收同比 | -15.8% | — |
| 净利润同比 | -52.3% | — |
| 每股收益（稀释后） | $-1.59 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PULMRZLV
| Q2 25 | — | $1.2M | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $5.9M | — | ||
| Q4 23 | $2.2M | — | ||
| Q3 23 | $1.8M | — | ||
| Q2 23 | $1.8M | — | ||
| Q1 23 | $1.5M | — | ||
| Q4 22 | $1.7M | — |
净利润PULMRZLV
| Q2 25 | — | $-13.0M | ||
| Q2 24 | $-5.8M | — | ||
| Q1 24 | $825.0K | — | ||
| Q4 23 | $-2.1M | — | ||
| Q3 23 | $-3.8M | — | ||
| Q2 23 | $-3.8M | — | ||
| Q1 23 | $-4.4M | — | ||
| Q4 22 | $-4.2M | — |
营业利润率PULMRZLV
| Q2 25 | — | -808.4% | ||
| Q2 24 | -380.2% | — | ||
| Q1 24 | 12.7% | — | ||
| Q4 23 | -101.0% | — | ||
| Q3 23 | -224.7% | — | ||
| Q2 23 | -216.4% | — | ||
| Q1 23 | -305.9% | — | ||
| Q4 22 | -253.2% | — |
净利率PULMRZLV
| Q2 25 | — | -1078.8% | ||
| Q2 24 | -374.4% | — | ||
| Q1 24 | 14.0% | — | ||
| Q4 23 | -94.6% | — | ||
| Q3 23 | -215.3% | — | ||
| Q2 23 | -206.9% | — | ||
| Q1 23 | -296.7% | — | ||
| Q4 22 | -246.8% | — |
每股收益（稀释后）PULMRZLV
| Q2 25 | — | — | ||
| Q2 24 | $-1.59 | — | ||
| Q1 24 | $0.23 | — | ||
| Q4 23 | $-0.58 | — | ||
| Q3 23 | $-1.03 | — | ||
| Q2 23 | $-1.04 | — | ||
| Q1 23 | $-1.22 | — | ||
| Q4 22 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $13.3M | $-14.3M |
| 总资产 | $15.8M | $80.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PULMRZLV
| Q2 25 | — | — | ||
| Q2 24 | $12.4M | — | ||
| Q1 24 | $16.3M | — | ||
| Q4 23 | $19.2M | — | ||
| Q3 23 | $21.3M | — | ||
| Q2 23 | $25.8M | — | ||
| Q1 23 | $30.8M | — | ||
| Q4 22 | $35.6M | — |
股东权益PULMRZLV
| Q2 25 | — | $-14.3M | ||
| Q2 24 | $13.3M | — | ||
| Q1 24 | $19.0M | — | ||
| Q4 23 | $18.0M | — | ||
| Q3 23 | $19.9M | — | ||
| Q2 23 | $23.4M | — | ||
| Q1 23 | $27.0M | — | ||
| Q4 22 | $31.1M | — |
总资产PULMRZLV
| Q2 25 | — | $80.1M | ||
| Q2 24 | $15.8M | — | ||
| Q1 24 | $30.4M | — | ||
| Q4 23 | $34.0M | — | ||
| Q3 23 | $36.8M | — | ||
| Q2 23 | $31.4M | — | ||
| Q1 23 | $36.1M | — | ||
| Q4 22 | $41.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.7M | $-4.9M |
| 自由现金流经营现金流 - 资本支出 | $-3.9M | — |
| 自由现金流率自由现金流/营收 | -252.6% | — |
| 资本支出强度资本支出/营收 | 15.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PULMRZLV
| Q2 25 | — | $-4.9M | ||
| Q2 24 | $-3.7M | — | ||
| Q1 24 | $-2.7M | — | ||
| Q4 23 | $-2.0M | — | ||
| Q3 23 | $-4.1M | — | ||
| Q2 23 | $-4.9M | — | ||
| Q1 23 | $-4.9M | — | ||
| Q4 22 | $-5.0M | — |
自由现金流PULMRZLV
| Q2 25 | — | — | ||
| Q2 24 | $-3.9M | — | ||
| Q1 24 | $-2.9M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-4.5M | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | $-5.1M | — |
自由现金流率PULMRZLV
| Q2 25 | — | — | ||
| Q2 24 | -252.6% | — | ||
| Q1 24 | -48.8% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -254.1% | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | -296.0% | — |
资本支出强度PULMRZLV
| Q2 25 | — | — | ||
| Q2 24 | 15.7% | — | ||
| Q1 24 | 2.6% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | 17.9% | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | 0.5% | — |
现金转化率PULMRZLV
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.30× | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
